Grenoble, France

Aurélie Juhem

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Curie, Université Joseph Fourier. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aurélie Juhem. Retrieved from https://idiyas.com/inventor/aurélie-juhem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aurélie Juhem: Innovator in Isoquinolone Research

Introduction

Aurélie Juhem is a notable inventor based in Grenoble, France. He has made significant contributions to the field of drug development, particularly through his research on isoquinolones. His work focuses on the synthesis and application of these compounds in treating various medical conditions, including cancer.

Latest Patents

Aurélie Juhem holds 1 patent for his invention titled "Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same." This patent details the use of isoquinolones in drug preparation, highlighting novel isoquinolone derivatives that are particularly effective in addressing pathological angiogenesis and cancer treatment.

Career Highlights

Throughout his career, Aurélie Juhem has been associated with prestigious institutions such as Université Joseph Fourier and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

One of his notable collaborators is Jean-Claude Florent. Their partnership has likely fostered innovative ideas and research advancements in the field of isoquinolone applications.

Conclusion

Aurélie Juhem's contributions to isoquinolone research exemplify the impact of innovative thinking in drug development. His work continues to pave the way for new treatments in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…